Detalhe da pesquisa
1.
Audit of sweat chloride testing reveals analytical errors.
Clin Chem Lab Med
; 59(8): 1376-1383, 2021 07 27.
Artigo
Inglês
| MEDLINE | ID: mdl-33826811
2.
Scoring Abdominal Symptoms in People with Cystic Fibrosis.
J Clin Med
; 13(6)2024 Mar 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38541878
3.
Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score.
Front Pharmacol
; 14: 1207356, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37205908
4.
Reduction in abdominal symptoms (CFAbd-Score), faecal M2-pyruvate-kinase and Calprotectin over one year of treatment with Elexacaftor-Tezacaftor-Ivacaftor in people with CF aged ≥12 years - The RECOVER study.
J Cyst Fibros
; 2023 Oct 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37806792
5.
Dynamics of abdominal symptoms during the start of a new therapy with elexacaftor/tezacaftor/ivacaftor using the novel CFAbd-day2day questionnaire.
Front Pharmacol
; 14: 1167407, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-38026920
6.
The potential of volatile organic compound analysis for pathogen detection and disease monitoring in patients with cystic fibrosis.
Expert Rev Respir Med
; 16(7): 723-735, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35853615
7.
Divergent dynamics of inflammatory mediators and multiplex PCRs during airway infection in cystic fibrosis patients and healthy controls: Serial upper airway sampling by nasal lavage.
Front Immunol
; 13: 947359, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36466839
8.
Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-Score.
Front Pharmacol
; 13: 877118, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35721187
9.
Would it have happened without Christmas? Thoracic emphysema and allergic bronchopulmonary aspergillosis in a juvenile cystic fibrosis patient with the G551D mutation receiving ivacaftor.
ERJ Open Res
; 7(2)2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-34046494
10.
Ivacaftor Reduces Inflammatory Mediators in Upper Airway Lining Fluid From Cystic Fibrosis Patients With a G551D Mutation: Serial Non-Invasive Home-Based Collection of Upper Airway Lining Fluid.
Front Immunol
; 12: 642180, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34025651
11.
Chronic rhinosinusitis in people with CF, a rapidly changing field.
J Cyst Fibros
; 23(2): 183-184, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38604889
12.
Diagnosing constipation in patients with cystic fibrosis applying ESPGHAN criteria.
J Cyst Fibros
; 21(3): 497-501, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34511390